Neuropace Stock Investor Sentiment
| NPCE Stock | USD 15.61 0.34 2.13% |
About 56% of Neuropace's investor base is looking to short. The analysis of overall sentiment of trading Neuropace stock suggests that many investors are alarmed at this time. The current market sentiment, together with Neuropace's historical and current headlines, can help investors time the market. In addition, many technical investors use Neuropace stock news signals to limit their universe of possible portfolio assets.
Comfort Level 44
Impartial
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Neuropace's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Neuropace.
News SentimentBullish | Hype SentimentBearish | Insider SentimentDisposing |
Neuropace Historical Sentiment
Although Neuropace's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Neuropace, such as negative comments on social media and news outlets, may cause fear in the market and push Neuropace's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Neuropace.
Neuropace | Build AI portfolio with Neuropace Stock |
Neuropace Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Neuropace can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Neuropace Historical Investor Sentiment
Investor biases related to Neuropace's public news can be used to forecast risks associated with an investment in Neuropace. The trend in average sentiment can be used to explain how an investor holding Neuropace can time the market purely based on public headlines and social activities around Neuropace. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Neuropace's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Neuropace and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Neuropace news discussions. The higher the estimate score, the more favorable the investor's outlook on Neuropace.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of Neuropace's Stock prices. Below is the latest headlines and news related to Neuropace Stock. Current markets are slightly bullish. About 55% of major world exchanges and indexes are currently up. See today's market update for more information.
There is far too much social signal, news, headlines, and media speculation about Neuropace that are available to investors today. This information is accessible both publicly - through Neuropace's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Neuropace-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Neuropace news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Neuropace relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Neuropace's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Neuropace alpha.
Neuropace Largest EPS Surprises
Earnings surprises can significantly impact Neuropace's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2025-08-12 | 2025-06-30 | -0.22 | -0.26 | -0.04 | 18 | ||
2024-08-13 | 2024-06-30 | -0.3 | -0.26 | 0.04 | 13 | ||
2021-11-10 | 2021-09-30 | -0.3 | -0.34 | -0.04 | 13 | ||
2025-03-03 | 2024-12-31 | -0.2233 | -0.18 | 0.0433 | 19 | ||
2023-05-04 | 2023-03-31 | -0.46 | -0.41 | 0.05 | 10 | ||
2024-11-12 | 2024-09-30 | -0.27 | -0.19 | 0.08 | 29 |
There is far too much social signal, news, headlines, and media speculation about Neuropace that are available to investors today. This information is accessible both publicly - through Neuropace's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Neuropace-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Neuropace news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Neuropace relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Neuropace's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Neuropace alpha.
Neuropace Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | NeuroPace Analysts Weekly Ratings Updates | 11/12/2025 |
2 | Disposition of 3051 shares by Martha Morrell of Neuropace at 13.5 subject to Rule 16b-3 | 11/20/2025 |
3 | Disposition of 1338 shares by Martha Morrell of Neuropace at 16.66 subject to Rule 16b-3 | 12/03/2025 |
4 | NeuroPace Announces Positive 18-Month NAUTILUS Trial Results in Idiopathic Generalized Epilepsy | 12/08/2025 |
5 | Wells Fargo Upgrades NeuroPace to Buy Rating, Raises Target Price to 19 - | 12/12/2025 |
6 | Is It Time To Consider Buying NeuroPace, Inc. | 12/17/2025 |
7 | Acquisition by Fischer Frank M of 1431 shares of Neuropace at 16.59 subject to Rule 16b-3 | 12/19/2025 |
8 | Acquisition by Fischer Frank M of 2303 shares of Neuropace at 10.31 subject to Rule 16b-3 | 12/26/2025 |
9 | UBS sees upside for NeuroPace shares with 22 percent CAGR and market expansion drivers - MSN | 01/05/2026 |
10 | NeuroPace Reports Preliminary Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 Outlook | 01/13/2026 |
11 | Disposition of 1430 shares by Martha Morrell of Neuropace at 12.56 subject to Rule 16b-3 | 01/21/2026 |
12 | NeuroPace stock price target raised to 19 from 18 at H.C. Wainwright - Investing.com Nigeria | 01/27/2026 |
Complementary Tools for Neuropace Stock analysis
When running Neuropace's price analysis, check to measure Neuropace's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neuropace is operating at the current time. Most of Neuropace's value examination focuses on studying past and present price action to predict the probability of Neuropace's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neuropace's price. Additionally, you may evaluate how the addition of Neuropace to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |